These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25924876)

  • 1. Activity of drugs and components of natural origin in the severe myoclonic epilepsy of infancy (Dravet syndrome).
    Berio A; Piazzi A
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):95-8. PubMed ID: 25924876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome.
    Weuring WJ; Singh S; Volkers L; Rook MB; van 't Slot RH; Bosma M; Inserra M; Vetter I; Verhoeven-Duif NM; Braun KPJ; Rivara M; Koeleman BPC
    PLoS One; 2020; 15(3):e0219106. PubMed ID: 32134913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome.
    Tiraboschi E; Martina S; van der Ent W; Grzyb K; Gawel K; Cordero-Maldonado ML; Poovathingal SK; Heintz S; Satheesh SV; Brattespe J; Xu J; Suster M; Skupin A; Esguerra CV
    Epilepsia; 2020 Mar; 61(3):549-560. PubMed ID: 32096222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral Comorbidities and Drug Treatments in a Zebrafish
    Grone BP; Qu T; Baraban SC
    eNeuro; 2017; 4(4):. PubMed ID: 28812061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.
    Zhang Y; Kecskés A; Copmans D; Langlois M; Crawford AD; Ceulemans B; Lagae L; de Witte PA; Esguerra CV
    PLoS One; 2015; 10(5):e0125898. PubMed ID: 25965391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.
    Baraban SC; Dinday MT; Hortopan GA
    Nat Commun; 2013; 4():2410. PubMed ID: 24002024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.
    Shi XY; Tomonoh Y; Wang WZ; Ishii A; Higurashi N; Kurahashi H; Kaneko S; Hirose S;
    Brain Dev; 2016 Jan; 38(1):40-6. PubMed ID: 26183863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and SCN1A gene mutation analysis of severe myoclonic epilepsy of infancy].
    Zhang YH; Sun HH; Liu XY; Ma XW; Yang ZX; Xiong H; Qin J; Lin Q; Wu XR
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):769-73. PubMed ID: 19099883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
    Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.
    Griffin A; Hamling KR; Knupp K; Hong S; Lee LP; Baraban SC
    Brain; 2017 Mar; 140(3):669-683. PubMed ID: 28073790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome.
    Cao D; Ohtani H; Ogiwara I; Ohtani S; Takahashi Y; Yamakawa K; Inoue Y
    Epilepsia; 2012 Jul; 53(7):1140-5. PubMed ID: 22578034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model.
    Hawkins NA; Lewis M; Hammond RS; Doherty JJ; Kearney JA
    Sci Rep; 2017 Nov; 7(1):15327. PubMed ID: 29127345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies.
    Fujiwara T
    Epilepsy Res; 2006 Aug; 70 Suppl 1():S223-30. PubMed ID: 16806826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons.
    Jiao J; Yang Y; Shi Y; Chen J; Gao R; Fan Y; Yao H; Liao W; Sun XF; Gao S
    Hum Mol Genet; 2013 Nov; 22(21):4241-52. PubMed ID: 23773995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child Neurology: Dravet syndrome: when to suspect the diagnosis.
    Millichap JJ; Koh S; Laux LC; Nordli DR
    Neurology; 2009 Sep; 73(13):e59-62. PubMed ID: 19786689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dravet syndrome: a genetic epileptic disorder.
    Akiyama M; Kobayashi K; Ohtsuka Y
    Acta Med Okayama; 2012; 66(5):369-76. PubMed ID: 23093055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [De novo SCN1A gene deletion in therapy-resistant Dravet syndrome].
    Bene J; Hadzsiev K; Komlósi K; Kövesdi E; Mátyás P; Melegh B
    Orv Hetil; 2015 Dec; 156(49):2009-12. PubMed ID: 26614543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SCN1A gene variants and epileptic encephalopathies.
    Parihar R; Ganesh S
    J Hum Genet; 2013 Sep; 58(9):573-80. PubMed ID: 23884151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.